Solid Biosciences (SLDB) has reported weaker-than-expected 1Q20 results, with FY GAAP EPS of -$2.91 missing Street consensus by $0.
More than 500 biotech companies operate in the US, doing their part to make it the world’s hub for innovation. Only about 20 …
US stocks look set to open higher on Thursday as investors tried to shake off concerns surrounding global trade. Today’s biggest movers and shakers on …
